A cure for the common cold? Culprit genome sequenced, but ...

Join Our Community of Science Lovers!

This article was published in Scientific American’s former blog network and reflects the views of the author, not necessarily those of Scientific American



On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


Could the common cold become a thing of the past? Scientists have unraveled the genetic code for all 99 strains of the rhinovirus, but there may be a disconnect between excitement over the feat in the lab versus at pharmaceutical companies that would ordinarily develop a cure or vaccine against infection.

The discovery, published this week in Science, means that, in theory, drug or vaccine developers have a map of possible targets against the cold virus. "There is real promise now, based on full understanding of this virus, that we have never had before," study co-author Stephen Liggett, a professor of medicine at the University of Maryland School of Medicine, told the Baltimore Sun. "Let's get, perhaps, a single pill [that] will kill the virus that day, that moment, and within six hours you are cured. It is possible."

But drug industry analysts are less enthusiastic. The cold might knock you out for a week or so, but it's not a major health threat to most people, raising the question of whether patients would bother paying for medicine, notes the New York Times. Relenza and Tamiflu, two antiviral drugs against another common virus, the flu, do work, but aren’t big moneymakers for manufacturers. Add to that the $700 million cost of developing a new medicine, and companies might not bother, experts told the newspaper.

Nonetheless, Fernando Martinez, a professor at the University of Arizona, told the Times that "it would be an extraordinary advance" if scientists could make anti-virals against the forms of the cold most likely to sicken asthma patients, who suffer more than most people when they catch a cold. In the interim, a good night's sleep may stop you from catching cold. And short of that … there's always grandma's chicken soup.

Image of rhinovirus via Wikimedia

It’s Time to Stand Up for Science

If you enjoyed this article, I’d like to ask for your support. Scientific American has served as an advocate for science and industry for 180 years, and right now may be the most critical moment in that two-century history.

I’ve been a Scientific American subscriber since I was 12 years old, and it helped shape the way I look at the world. SciAm always educates and delights me, and inspires a sense of awe for our vast, beautiful universe. I hope it does that for you, too.

If you subscribe to Scientific American, you help ensure that our coverage is centered on meaningful research and discovery; that we have the resources to report on the decisions that threaten labs across the U.S.; and that we support both budding and working scientists at a time when the value of science itself too often goes unrecognized.

In return, you get essential news, captivating podcasts, brilliant infographics, can't-miss newsletters, must-watch videos, challenging games, and the science world's best writing and reporting. You can even gift someone a subscription.

There has never been a more important time for us to stand up and show why science matters. I hope you’ll support us in that mission.

Thank you,

David M. Ewalt, Editor in Chief, Scientific American

Subscribe